Product Information
AMLODIPINE-ATORVAST 5-10 MG is a generic product labeled by Prasco Laboratories, priced at $1.0811 per EA under NDC 66993026630. Its NADAC has been published 219 times since Jul 27, 2022.
FDA first approved this application on Jan 30, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5; 10 mg/1; mg/1
Manufacturer
Prasco LaboratoriesNDC
66993026630
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021540FDA Approved
1/30/2004
TE Code
AB
On Market Since
3/14/2022
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-ATORVAST 5-10 MG has been published 219 times since Jul 27, 2022, and over the history we have for it it has declined 41.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0811 per EA |
|---|---|
| All-time high | $2.9090 (Jan 10, 2024) |
| All-time low | $0.7019 (Jul 17, 2024) |
| 52-week high | $1.3847 |
| 52-week low | $1.0211 |
| Median price | $1.1832 |
| Average price | $1.4568 |
| Largest weekly change | +78.9% (Oct 19, 2022) |
| Weeks tracked | 219 |
| Tracking since | Jul 27, 2022 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Prasco Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Amlodipine and Atorvastatin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMLODIPINE-ATORVAST 5-10 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-ATORVAST 5-10 MG, manufactured by Prasco Laboratories, is $1.0811 per EA (NDC 66993026630), effective Sep 30, 2026.
How has the price of AMLODIPINE-ATORVAST 5-10 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-ATORVAST 5-10 MG has declined 41.5%. It has been tracked across 219 weekly CMS publications since Jul 27, 2022.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-ATORVAST 5-10 MG?
Since Jul 27, 2022, the NADAC for AMLODIPINE-ATORVAST 5-10 MG has ranged from a low of $0.7019 (Jul 17, 2024) to a high of $2.9090 (Jan 10, 2024), with a median of $1.1832 per EA.
Are there cheaper alternatives to AMLODIPINE-ATORVAST 5-10 MG?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-ATORVAST 5-10 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures AMLODIPINE-ATORVAST 5-10 MG?
AMLODIPINE-ATORVAST 5-10 MG (NDC 66993026630) is labeled by Prasco Laboratories, and CMS classifies it as a generic product.